Sildenafil | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Sildenafil | Cytochrome P450 2C9 | enzyme |
Sildenafil | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | target |
Sildenafil | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | target |
Sildenafil | Cytochrome P450 3A4 | enzyme |
Sildenafil | Cytochrome P450 3A5 | enzyme |
Sildenafil | Cytochrome P450 3A7 | enzyme |
Sildenafil | Multidrug resistance-associated protein 4 | transporter |
Sildenafil | Multidrug resistance-associated protein 5 | transporter |
Sildenafil | Multidrug resistance-associated protein 7 | transporter |
Sildenafil | Cytochrome P450 2C19 | enzyme |
Sildenafil | Cytochrome P450 2D6 | enzyme |
Sildenafil | Cytochrome P450 2E1 | enzyme |
Sildenafil | Solute carrier organic anion transporter family member 1B1 | transporter |
Sildenafil | P-glycoprotein 1 | transporter |
Sildenafil | Ornithine decarboxylase | target |
Sildenafil | Programmed cell death 1 ligand 1 | target |
Tadalafil | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Tadalafil | Cytochrome P450 3A4 | enzyme |
Tadalafil | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | target |
Tadalafil | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | target |
Vardenafil | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Vardenafil | Cytochrome P450 3A4 | enzyme |
Vardenafil | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | target |
Vardenafil | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | target |
Vardenafil | Cytochrome P450 3A5 | enzyme |
Vardenafil | P-glycoprotein 1 | transporter |
Vardenafil | Cytochrome P450 2C9 | enzyme |
Vardenafil | Cytochrome P450 2C8 | enzyme |
Vardenafil | Cytochrome P450 2C19 | enzyme |
Vardenafil | Cytochrome P450 2D6 | enzyme |
Udenafil | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Udenafil | Cytochrome P450 3A4 | enzyme |
Udenafil | Cytochrome P450 3A5 | enzyme |
Mirodenafil | Cytochrome P450 3A Subfamily | enzyme |
Avanafil | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Avanafil | Cytochrome P450 3A4 | enzyme |
Avanafil | Serum albumin | carrier |
Avanafil | Alpha-1-acid glycoprotein 1 | carrier |
Avanafil | P-glycoprotein 1 | transporter |
Avanafil | ATP-binding cassette sub-family G member 2 | transporter |
Avanafil | Cytochrome P450 2C9 | enzyme |
Dipyridamole | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | target |
Dipyridamole | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Dipyridamole | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | target |
Dipyridamole | Adenosine deaminase | target |
Dipyridamole | Multidrug resistance-associated protein 4 | transporter |
Dipyridamole | Multidrug resistance-associated protein 5 | transporter |
Dipyridamole | P-glycoprotein 1 | transporter |
Dipyridamole | Calcipressin-1 | target |
Dipyridamole | Alpha-1-acid glycoprotein 1 | target |
Dipyridamole | Solute carrier organic anion transporter family member 1B1 | transporter |
Dipyridamole | Solute carrier organic anion transporter family member 1B3 | transporter |
Dipyridamole | Solute carrier organic anion transporter family member 2B1 | transporter |
Dipyridamole | Bile salt export pump | transporter |
Pentoxifylline | 5'-nucleotidase | target |
Pentoxifylline | Adenosine receptor A1 | target |
Pentoxifylline | Adenosine receptor A2a | target |
Pentoxifylline | Cytochrome P450 1A2 | enzyme |
Pentoxifylline | Phosphodiesterase enzymes | target |
Theophylline | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | target |
Theophylline | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | target |
Theophylline | Adenosine receptor A2b | target |
Theophylline | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | target |
Theophylline | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Theophylline | Adenosine receptor A1 | target |
Theophylline | Adenosine receptor A2a | target |
Theophylline | Cytochrome P450 1A2 | enzyme |
Theophylline | Adenosine deaminase | enzyme |
Theophylline | Cytochrome P450 2E1 | enzyme |
Theophylline | Cytochrome P450 3A4 | enzyme |
Theophylline | Solute carrier family 22 member 7 | transporter |
Theophylline | Cytochrome P450 1A1 | enzyme |
Theophylline | Cytochrome P450 1B1 | enzyme |
Theophylline | Cytochrome P450 2D6 | enzyme |
Theophylline | Histone deacetylase 2 | target |
Theophylline | Copine-1 | target |
Theophylline | Minor histocompatibility antigen H13 | target |
Theophylline | Nodal modulator 1 | target |
Theophylline | Poly [ADP-ribose] polymerase 1 | target |
Theophylline | Protein RIC-3 | target |
Theophylline | Tubulin monoglycylase TTLL3 | target |
Fostamatinib | Adenosine receptor A3 | target |
Fostamatinib | vesicular monoamine transporter 2 (VMAT2) | target |
Fostamatinib | Fatty-acid amide hydrolase 1 | target |
Fostamatinib | Equilibrative nucleoside transporter 1 | target |
Fostamatinib | UDP-glucuronosyltransferase 1-1 | target |
Fostamatinib | cGMP-specific 3',5'-cyclic phosphodiesterase | target |
Fostamatinib | Arachidonate 5-lipoxygenase | target |
Fostamatinib | Cathepsin S | target |
Fostamatinib | Cathepsin L1 | target |
Fostamatinib | Tyrosine-protein kinase ABL1 | target |
Fostamatinib | Calcium-dependent protein kinase 1 | target |
Fostamatinib | Serine/threonine-protein kinase PknB | target |
Fostamatinib | Ribosomal protein S6 kinase alpha-6 | target |
Fostamatinib | Non-receptor tyrosine-protein kinase TYK2 | target |
Fostamatinib | Atypical kinase COQ8A, mitochondrial | target |
Fostamatinib | Tyrosine-protein kinase JAK1 | target |
Fostamatinib | Hepatocyte growth factor receptor | target |
Fostamatinib | Serine/threonine-protein kinase NIM1 | target |
Fostamatinib | Serine/threonine-protein kinase MST4 | target |
Fostamatinib | cAMP-dependent protein kinase catalytic subunit alpha | target |
Fostamatinib | Serine/threonine-protein kinase 24 | target |
Fostamatinib | Serine/threonine-protein kinase 3 | target |
Fostamatinib | Tyrosine-protein kinase Tec | target |
Fostamatinib | Tyrosine-protein kinase SYK | target |
Fostamatinib | Serine/threonine-protein kinase 33 | target |
Fostamatinib | Serine/threonine-protein kinase 35 | target |
Fostamatinib | Serine/threonine-protein kinase 36 | target |
Fostamatinib | Serine/threonine-protein kinase 38 | target |
Fostamatinib | Serine/threonine-protein kinase 38-like | target |
Fostamatinib | STE20/SPS1-related proline-alanine-rich protein kinase | target |
Fostamatinib | Serine/threonine-protein kinase TAO1 | target |
Fostamatinib | Serine/threonine-protein kinase TAO2 | target |
Fostamatinib | Serine/threonine-protein kinase TAO3 | target |
Fostamatinib | Serine/threonine-protein kinase TBK1 | target |
Fostamatinib | Angiopoietin-1 receptor | target |
Fostamatinib | Dual specificity testis-specific protein kinase 1 | target |
Fostamatinib | TGF-beta receptor type-1 | target |
Fostamatinib | TGF-beta receptor type-2 | target |
Fostamatinib | Tyrosine-protein kinase receptor Tie-1 | target |
Fostamatinib | Serine/threonine-protein kinase tousled-like 1 | target |
Fostamatinib | Serine/threonine-protein kinase tousled-like 2 | target |
Fostamatinib | TRAF2 and NCK-interacting protein kinase | target |
Fostamatinib | Non-receptor tyrosine-protein kinase TNK1 | target |
Fostamatinib | Activated CDC42 kinase 1 | target |
Fostamatinib | Serine/threonine-protein kinase TNNI3K | target |
Fostamatinib | Testis-specific serine/threonine-protein kinase 1 | target |
Fostamatinib | Dual specificity protein kinase TTK | target |
Fostamatinib | Tyrosine-protein kinase TXK | target |
Fostamatinib | Tyrosine-protein kinase receptor TYRO3 | target |
Fostamatinib | Serine/threonine-protein kinase ULK1 | target |
Fostamatinib | Serine/threonine-protein kinase ULK2 | target |
Fostamatinib | Serine/threonine-protein kinase ULK3 | target |
Fostamatinib | Wee1-like protein kinase | target |
Fostamatinib | Tyrosine-protein kinase Yes | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 19 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase MLT | target |
Fostamatinib | Tyrosine-protein kinase ZAP-70 | target |
Fostamatinib | AP2-associated protein kinase 1 | target |
Fostamatinib | Tyrosine-protein kinase ABL2 | target |
Fostamatinib | Activin receptor type-1 | target |
Fostamatinib | Activin receptor type-1B | target |
Fostamatinib | Atypical kinase COQ8B, mitochondrial | target |
Fostamatinib | ALK tyrosine kinase receptor | target |
Fostamatinib | Ankyrin repeat and protein kinase domain-containing protein 1 | target |
Fostamatinib | Aurora kinase A | target |
Fostamatinib | Aurora kinase B | target |
Fostamatinib | Aurora kinase C | target |
Fostamatinib | Tyrosine-protein kinase receptor UFO | target |
Fostamatinib | Tyrosine-protein kinase Blk | target |
Fostamatinib | BMP-2-inducible protein kinase | target |
Fostamatinib | Bone morphogenetic protein receptor type-1B | target |
Fostamatinib | Bone morphogenetic protein receptor type-2 | target |
Fostamatinib | Cytoplasmic tyrosine-protein kinase BMX | target |
Fostamatinib | Serine/threonine-protein kinase B-raf | target |
Fostamatinib | Tyrosine-protein kinase BTK | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase type 1 | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase type 1D | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase type 1G | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase type II subunit alpha | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase type II subunit beta | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase type II subunit delta | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase type II subunit gamma | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase kinase 1 | target |
Fostamatinib | Calcium/calmodulin-dependent protein kinase kinase 2 | target |
Fostamatinib | Peripheral plasma membrane protein CASK | target |
Fostamatinib | Kappa-casein | target |
Fostamatinib | Cyclin-dependent kinase 1 | target |
Fostamatinib | Serine/threonine-protein kinase MRCK gamma | target |
Fostamatinib | Cyclin-dependent kinase 4 | target |
Fostamatinib | Cyclin-dependent kinase-like 1 | target |
Fostamatinib | Cyclin-dependent kinase-like 2 | target |
Fostamatinib | Serine/threonine-protein kinase Chk1 | target |
Fostamatinib | Serine/threonine-protein kinase Chk2 | target |
Fostamatinib | Citron Rho-interacting kinase | target |
Fostamatinib | Dual specificity protein kinase CLK1 | target |
Fostamatinib | Dual specificity protein kinase CLK2 | target |
Fostamatinib | Dual specificity protein kinase CLK3 | target |
Fostamatinib | Dual specificity protein kinase CLK4 | target |
Fostamatinib | Macrophage colony-stimulating factor 1 receptor | target |
Fostamatinib | Tyrosine-protein kinase CSK | target |
Fostamatinib | Casein kinase I isoform alpha | target |
Fostamatinib | Casein kinase II subunit alpha | target |
Fostamatinib | Casein kinase II subunit alpha' | target |
Fostamatinib | Death-associated protein kinase 1 | target |
Fostamatinib | Death-associated protein kinase 2 | target |
Fostamatinib | Death-associated protein kinase 3 | target |
Fostamatinib | Serine/threonine-protein kinase DCLK1 | target |
Fostamatinib | Serine/threonine-protein kinase DCLK2 | target |
Fostamatinib | Serine/threonine-protein kinase DCLK3 | target |
Fostamatinib | Epithelial discoidin domain-containing receptor 1 | target |
Fostamatinib | Discoidin domain-containing receptor 2 | target |
Fostamatinib | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | target |
Fostamatinib | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | target |
Fostamatinib | Epidermal growth factor receptor | target |
Fostamatinib | Eukaryotic translation initiation factor 2-alpha kinase 1 | target |
Fostamatinib | Interferon-induced, double-stranded RNA-activated protein kinase | target |
Fostamatinib | eIF-2-alpha kinase GCN2 | target |
Fostamatinib | Ephrin type-A receptor 1 | target |
Fostamatinib | Ephrin type-A receptor 2 | target |
Fostamatinib | Ephrin type-A receptor 3 | target |
Fostamatinib | Ephrin type-A receptor 4 | target |
Fostamatinib | Ephrin type-A receptor 5 | target |
Fostamatinib | Ephrin type-A receptor 6 | target |
Fostamatinib | Ephrin type-A receptor 7 | target |
Fostamatinib | Ephrin type-A receptor 8 | target |
Fostamatinib | Ephrin type-B receptor 1 | target |
Fostamatinib | Ephrin type-B receptor 2 | target |
Fostamatinib | Ephrin type-B receptor 4 | target |
Fostamatinib | Ephrin type-B receptor 6 | target |
Fostamatinib | Receptor tyrosine-protein kinase erbB-2 | target |
Fostamatinib | Receptor tyrosine-protein kinase erbB-4 | target |
Fostamatinib | Serine/threonine-protein kinase/endoribonuclease IRE1 | target |
Fostamatinib | Tyrosine-protein kinase Fer | target |
Fostamatinib | Tyrosine-protein kinase Fes/Fps | target |
Fostamatinib | Fibroblast growth factor receptor 1 | target |
Fostamatinib | Fibroblast growth factor receptor 2 | target |
Fostamatinib | Fibroblast growth factor receptor 3 | target |
Fostamatinib | Tyrosine-protein kinase Fgr | target |
Fostamatinib | Vascular endothelial growth factor receptor 1 | target |
Fostamatinib | Receptor-type tyrosine-protein kinase FLT3 | target |
Fostamatinib | Vascular endothelial growth factor receptor 3 | target |
Fostamatinib | Serine/threonine-protein kinase mTOR | target |
Fostamatinib | Tyrosine-protein kinase FRK | target |
Fostamatinib | Tyrosine-protein kinase Fyn | target |
Fostamatinib | Cyclin-G-associated kinase | target |
Fostamatinib | Glycogen synthase kinase-3 alpha | target |
Fostamatinib | Glycogen synthase kinase-3 beta | target |
Fostamatinib | Tyrosine-protein kinase HCK | target |
Fostamatinib | Homeodomain-interacting protein kinase 2 | target |
Fostamatinib | Homeodomain-interacting protein kinase 3 | target |
Fostamatinib | Serine/threonine-protein kinase ICK | target |
Fostamatinib | Inhibitor of nuclear factor kappa-B kinase subunit beta | target |
Fostamatinib | Inhibitor of nuclear factor kappa-B kinase subunit epsilon | target |
Fostamatinib | Insulin receptor | target |
Fostamatinib | Insulin receptor-related protein | target |
Fostamatinib | Interleukin-1 receptor-associated kinase 1 | target |
Fostamatinib | Interleukin-1 receptor-associated kinase 3 | target |
Fostamatinib | Interleukin-1 receptor-associated kinase 4 | target |
Fostamatinib | Tyrosine-protein kinase ITK/TSK | target |
Fostamatinib | Tyrosine-protein kinase JAK2 | target |
Fostamatinib | Tyrosine-protein kinase JAK3 | target |
Fostamatinib | Vascular endothelial growth factor receptor 2 | target |
Fostamatinib | Serine/threonine-protein kinase SIK3 | target |
Fostamatinib | Mast/stem cell growth factor receptor Kit | target |
Fostamatinib | Serine/threonine-protein kinase LATS1 | target |
Fostamatinib | Tyrosine-protein kinase Lck | target |
Fostamatinib | LIM domain kinase 1 | target |
Fostamatinib | LIM domain kinase 2 | target |
Fostamatinib | Leucine-rich repeat serine/threonine-protein kinase 2 | target |
Fostamatinib | Leukocyte tyrosine kinase receptor | target |
Fostamatinib | Tyrosine-protein kinase Lyn | target |
Fostamatinib | Dual specificity mitogen-activated protein kinase kinase 2 | target |
Fostamatinib | Dual specificity mitogen-activated protein kinase kinase 3 | target |
Fostamatinib | Dual specificity mitogen-activated protein kinase kinase 5 | target |
Fostamatinib | Dual specificity mitogen-activated protein kinase kinase 6 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 1 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 10 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 11 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 12 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 13 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 15 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 2 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 3 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 4 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 6 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase 9 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase kinase 1 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase kinase 2 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase kinase 3 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase kinase 4 | target |
Fostamatinib | Mitogen-activated protein kinase kinase kinase kinase 5 | target |
Fostamatinib | Mitogen-activated protein kinase 10 | target |
Fostamatinib | Mitogen-activated protein kinase 13 | target |
Fostamatinib | Mitogen-activated protein kinase 14 | target |
Fostamatinib | Mitogen-activated protein kinase 15 | target |
Fostamatinib | Mitogen-activated protein kinase 4 | target |
Fostamatinib | Mitogen-activated protein kinase 7 | target |
Fostamatinib | Mitogen-activated protein kinase 9 | target |
Fostamatinib | MAP kinase-activated protein kinase 5 | target |
Fostamatinib | Serine/threonine-protein kinase MARK1 | target |
Fostamatinib | Serine/threonine-protein kinase MARK2 | target |
Fostamatinib | MAP/microtubule affinity-regulating kinase 3 | target |
Fostamatinib | MAP/microtubule affinity-regulating kinase 4 | target |
Fostamatinib | CLIP-associating protein 1 | target |
Fostamatinib | Microtubule-associated serine/threonine-protein kinase 1 | target |
Fostamatinib | Megakaryocyte-associated tyrosine-protein kinase | target |
Fostamatinib | Maternal embryonic leucine zipper kinase | target |
Fostamatinib | Tyrosine-protein kinase Mer | target |
Fostamatinib | Misshapen-like kinase 1 | target |
Fostamatinib | MAP kinase-interacting serine/threonine-protein kinase 1 | target |
Fostamatinib | MAP kinase-interacting serine/threonine-protein kinase 2 | target |
Fostamatinib | Macrophage-stimulating protein receptor | target |
Fostamatinib | Muscle, skeletal receptor tyrosine-protein kinase | target |
Fostamatinib | Myosin light chain kinase, smooth muscle | target |
Fostamatinib | Myosin light chain kinase 2, skeletal/cardiac muscle | target |
Fostamatinib | Myosin light chain kinase 3 | target |
Fostamatinib | Myosin light chain kinase family member 4 | target |
Fostamatinib | Myosin-IIIa | target |
Fostamatinib | Serine/threonine-protein kinase Nek1 | target |
Fostamatinib | Serine/threonine-protein kinase Nek11 | target |
Fostamatinib | Serine/threonine-protein kinase Nek2 | target |
Fostamatinib | Serine/threonine-protein kinase Nek3 | target |
Fostamatinib | Serine/threonine-protein kinase Nek4 | target |
Fostamatinib | Serine/threonine-protein kinase Nek5 | target |
Fostamatinib | Serine/threonine-protein kinase Nek9 | target |
Fostamatinib | High affinity nerve growth factor receptor | target |
Fostamatinib | BDNF/NT-3 growth factors receptor | target |
Fostamatinib | NT-3 growth factor receptor | target |
Fostamatinib | NUAK family SNF1-like kinase 1 | target |
Fostamatinib | NUAK family SNF1-like kinase 2 | target |
Fostamatinib | Serine/threonine-protein kinase OSR1 | target |
Fostamatinib | Serine/threonine-protein kinase PAK 1 | target |
Fostamatinib | Serine/threonine-protein kinase PAK 2 | target |
Fostamatinib | Serine/threonine-protein kinase PAK 3 | target |
Fostamatinib | Serine/threonine-protein kinase PAK 4 | target |
Fostamatinib | Serine/threonine-protein kinase PAK 6 | target |
Fostamatinib | Serine/threonine-protein kinase PAK 5 | target |
Fostamatinib | Cyclin-dependent kinase 16 | target |
Fostamatinib | Cyclin-dependent kinase 17 | target |
Fostamatinib | Platelet-derived growth factor receptor alpha | target |
Fostamatinib | Platelet-derived growth factor receptor beta | target |
Fostamatinib | 3-phosphoinositide-dependent protein kinase 1 | target |
Fostamatinib | Cyclin-dependent kinase 15 | target |
Fostamatinib | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | target |
Fostamatinib | Phosphatidylinositol 4-kinase beta | target |
Fostamatinib | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | target |
Fostamatinib | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma | target |
Fostamatinib | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | target |
Fostamatinib | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | target |
Fostamatinib | Serine/threonine-protein kinase pim-1 | target |
Fostamatinib | Serine/threonine-protein kinase pim-3 | target |
Fostamatinib | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | target |
Fostamatinib | Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | target |
Fostamatinib | Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | target |
Fostamatinib | Serine/threonine-protein kinase N1 | target |
Fostamatinib | Serine/threonine-protein kinase N2 | target |
Fostamatinib | Serine/threonine-protein kinase PLK1 | target |
Fostamatinib | Serine/threonine-protein kinase PLK2 | target |
Fostamatinib | Serine/threonine-protein kinase PLK3 | target |
Fostamatinib | Serine/threonine-protein kinase PLK4 | target |
Fostamatinib | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | target |
Fostamatinib | 5'-AMP-activated protein kinase | target |
Fostamatinib | cAMP-dependent protein kinase catalytic subunit beta | target |
Fostamatinib | Protein kinase C delta type | target |
Fostamatinib | Protein kinase C epsilon type | target |
Fostamatinib | Protein kinase C gamma type (PRKCG) | target |
Fostamatinib | Protein kinase C iota type | target |
Fostamatinib | Protein kinase C theta type | target |
Fostamatinib | Serine/threonine-protein kinase D1 | target |
Fostamatinib | cGMP-dependent protein kinase 2 | target |
Fostamatinib | Serine/threonine-protein kinase PRP4 homolog | target |
Fostamatinib | Focal adhesion kinase 1 | target |
Fostamatinib | Protein-tyrosine kinase 2-beta | target |
Fostamatinib | Protein-tyrosine kinase 6 | target |
Fostamatinib | RAF proto-oncogene serine/threonine-protein kinase | target |
Fostamatinib | Proto-oncogene tyrosine-protein kinase receptor Ret | target |
Fostamatinib | Serine/threonine-protein kinase RIO1 | target |
Fostamatinib | Serine/threonine-protein kinase RIO2 | target |
Fostamatinib | Serine/threonine-protein kinase RIO3 | target |
Fostamatinib | Receptor-interacting serine/threonine-protein kinase 1 | target |
Fostamatinib | Receptor-interacting serine/threonine-protein kinase 2 | target |
Fostamatinib | Receptor-interacting serine/threonine-protein kinase 4 | target |
Fostamatinib | Rho-associated protein kinase 2 | target |
Fostamatinib | Proto-oncogene tyrosine-protein kinase ROS | target |
Fostamatinib | Ribosomal protein S6 kinase alpha-1 | target |
Fostamatinib | Ribosomal protein S6 kinase alpha-3 | target |
Fostamatinib | Serine/threonine-protein kinase SBK1 | target |
Fostamatinib | Uncharacterized serine/threonine-protein kinase SBK3 | target |
Fostamatinib | Serine/threonine-protein kinase Sgk3 | target |
Fostamatinib | Serine/threonine-protein kinase SIK1 | target |
Fostamatinib | Serine/threonine-protein kinase SIK2 | target |
Fostamatinib | STE20-like serine/threonine-protein kinase | target |
Fostamatinib | SNF-related serine/threonine-protein kinase | target |
Fostamatinib | Proto-oncogene tyrosine-protein kinase Src | target |
Fostamatinib | Tyrosine-protein kinase Srms | target |
Fostamatinib | Serine/threonine-protein kinase 10 | target |
Fostamatinib | Serine/threonine-protein kinase 16 | target |
Fostamatinib | Serine/threonine-protein kinase 17A | target |
Fostamatinib | Serine/threonine-protein kinase 17B | target |
Fostamatinib | Serine/threonine-protein kinase 32A | target |
Fostamatinib | Cytochrome P450 3A4 | enzyme |
Fostamatinib | ATP-binding cassette sub-family G member 2 | transporter |
Fostamatinib | ATP-binding cassette sub-family B member 5 | transporter |
Fostamatinib | UDP-glucuronosyltransferase 1-9 | enzyme |
Ibudilast | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | target |
Ibudilast | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | target |
Ibudilast | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | target |
Ibudilast | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | target |
Ibudilast | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | target |
Doxofylline | Adenosine receptor A2a | target |
Doxofylline | Beta-2 adrenergic receptor | target |
Doxofylline | Cytochrome P450 1A2 | enzyme |
Doxofylline | cGMP-dependent 3',5'-cyclic phosphodiesterase | target |